N/A
Completed N=86
Feasibility of SBIRT-PN
Substance Use Disorder · HIV · Older Adults · Behavioral Intervention
Source: ClinicalTrials.gov NCT03057119 ↗
Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Number of Participants Ranking Intervention as Acceptable — 9; 5 Participants
Summary
Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Ranking Intervention as Acceptable |
9; 5 | — |
| SECONDARY Number of Participants Who Obtained Formal Substance Use Treatment |
1; 1 | — |
| SECONDARY Number of Participants Who Used Different Types of Substances (Self-Reported) |
16; 17; 5; 4; 1; 2 | — |
| SECONDARY Number of Participants Who Used Different Types of Substances (Biologically Confirmed Via Urinalysis) |
16; 17; 1; 1; 3; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Receiving care at an Infectious disease Medical Clinic
- HIV-positive (seropositive confirmed by medical records)
- have a substance misuse screening score indicating moderate or high risk.
Exclusion Criteria
- lack fluency in English
- are unwilling to provide information for follow-up
- plan to leave the area within 6 months
- already have a referral to treatment from another provider
- unable to provide informed consent due to cognitive impairment.
Data sourced from ClinicalTrials.gov (NCT03057119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.